1
|
Jafari M, Abolmaali SS, Borandeh S, Najafi H, Zareshahrabadi Z, Koohi-Hosseinabadi O, Azarpira N, Zomorodian K, Tamaddon AM. Dendritic hybrid materials comprising polyhedral oligomeric silsesquioxane (POSS) and hyperbranched polyglycerol for effective antifungal drug delivery and therapy in systemic candidiasis. NANOSCALE 2023; 15:16163-16177. [PMID: 37772640 DOI: 10.1039/d3nr04321e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/30/2023]
Abstract
Systemic Candida infections are routinely treated with amphotericin B (AMB), a highly effective antimycotic drug. However, due to severe toxicities linked to the parenteral administration of conventional micellar formulations (Fungizone®), its clinical utility is limited. Hyperbranched polyglycerols (HPGs) are multi-branched three-dimensional hydrophilic macromolecules that can be used to lessen the toxicity of AMB while also increasing its aqueous solubility. In the current research, to improve the safety and therapeutic efficacy of AMB, we developed new polyhedral oligomeric silsesquioxane - hyperbranched polyglycerol dendrimers with cholesterol termini (POSS-HPG@Chol) using azide-alkyne click reaction. Compared with Fungizone®, the as-synthesized POSS-HPG@Chol/AMB had lower minimum inhibitory and fungicidal concentrations against almost all studied Candida spp., as well as much less hemolysis and cytotoxicity. POSS-HPG@Chol/AMB revealed total protection of Balb/C mice from severe Candida infections in an experimental model of systemic candidiasis and can effectively reduce or eliminate AMB liver and kidney tissue injuries. Thanks to their safety, biocompatibility, and unique therapeutic properties, the developed POSS-polyglycerol dendrimers could be viable nanostructures for the delivery of poorly soluble drugs like AMB.
Collapse
Affiliation(s)
- Mahboobeh Jafari
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
- Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
| | - Samira Sadat Abolmaali
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
- Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
| | - Sedigheh Borandeh
- Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
| | - Haniyeh Najafi
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
| | - Zahra Zareshahrabadi
- Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, PO Box 713484-5794, Shiraz, Iran.
| | - Omid Koohi-Hosseinabadi
- Central Research Laboratory, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
| | - Negar Azarpira
- Transplant Research Center, Shiraz University of Medical Sciences, Mohammad Rasoul-allah Research Tower, PO Box 7193711351, Shiraz, Iran.
| | - Kamiar Zomorodian
- Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, PO Box 713484-5794, Shiraz, Iran.
- Department of Medical Parasitology and Mycology, Shiraz University of Medical Sciences, PO Box 713484-5794, Shiraz, Iran
| | - Ali Mohammad Tamaddon
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
- Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, PO Box 71345-1583, Shiraz, Iran.
| |
Collapse
|
2
|
Radbruch M, Pischon H, Du F, Haag R, Schumacher F, Kleuser B, Mundhenk L, Gruber AD. Biodegradable core-multishell nanocarrier: Topical tacrolimus delivery for treatment of dermatitis. J Control Release 2022; 349:917-928. [PMID: 35905785 DOI: 10.1016/j.jconrel.2022.07.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Revised: 06/22/2022] [Accepted: 07/20/2022] [Indexed: 10/15/2022]
Abstract
Two challenges in topical drug delivery to the skin include solubilizing hydrophobic drugs in water-based formulations and increasing drug penetration into the skin. Polymeric core-multishell nanocarrier (CMS), particularly the novel biodegradable CMS (bCMS = hPG-PCL1.1K-mPEG2k-CMS) have shown both advantages on excised skin ex vivo. Here, we investigated topical delivery of tacrolimus (TAC; > 500 g/mol) by bCMS in a hydrogel on an oxazolone-induced model of dermatitis in vivo. As expected, bCMS successfully delivered TAC into the skin. However, in vivo they did not increase, but decrease TAC penetration through the stratum corneum compared to ointment. Differences in the resulting mean concentrations were mostly non-significant in the skin (epidermis: 35.7 ± 20.9 ng/cm2 for bCMS vs. 92.6 ± 62.7 ng/cm2 for ointment; dermis: 76.8 ± 26.8 ng/cm2vs 118.2 ± 50.4 ng/cm2), but highly significant in blood (plasma: 1.1 ± 0.4 ng/ml vs 11.3 ± 9.3 ng/ml; erythrocytes: 0.5 ± 0.2 ng/ml vs 3.4 ± 2.4 ng/ml) and liver (0.01 ± 0.01 ng/mg vs 0.03 ± 0.01 ng/mg). bCMS were detected in the stratum corneum but not in viable skin or beyond. The therapeutic efficacy of TAC delivered by bCMS was equivalent to that of standard TAC ointment. Our results suggest that bCMS may be a promising carrier for the topical delivery of TAC. The quantitative difference to previous results should be interpreted in light of structural differences between murine and human skin, but highlights the need as well as potential methods to develop more a complex ex vivo analysis on human skin to ensure quantitative predictive value.
Collapse
Affiliation(s)
- Moritz Radbruch
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag Str. 15, 14163 Berlin, Germany
| | - Hannah Pischon
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag Str. 15, 14163 Berlin, Germany
| | - Fang Du
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany
| | - Rainer Haag
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustraße 3, 14195 Berlin, Germany
| | - Fabian Schumacher
- Department for Nutritional Toxicology, Universität Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany; Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany
| | - Burkhard Kleuser
- Department for Nutritional Toxicology, Universität Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany; Institute of Pharmacy, Freie Universität Berlin, Königin-Luise-Str. 2+4, 14195 Berlin, Germany
| | - Lars Mundhenk
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag Str. 15, 14163 Berlin, Germany
| | - Achim D Gruber
- Institute of Veterinary Pathology, Freie Universität Berlin, Robert-von-Ostertag Str. 15, 14163 Berlin, Germany.
| |
Collapse
|
3
|
Jafari M, Abolmaali SS, Borandeh S, Najafi H, Zareshahrabadi Z, Heidari R, Azarpira N, Zomorodian K, Tamaddon AM. Amphiphilic hyperbranched polyglycerol nanoarchitectures for Amphotericin B delivery in Candida infections. BIOMATERIALS ADVANCES 2022; 139:212996. [PMID: 35891600 DOI: 10.1016/j.bioadv.2022.212996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2022] [Revised: 05/23/2022] [Accepted: 06/17/2022] [Indexed: 06/15/2023]
Abstract
Although Amphotericin B (AMB) is considered the most effective anti-mycotic agent for treating Candida infections, its clinical use is limited due to its high toxicity. To address this issue, we developed cholesterol-based dendritic micelles of hyperbranched polyglycerol (HPG), including cholesterol-cored HPG (Chol-HPG) and cholesterol end-capped HPG (HPG@Chol), for AMB delivery. The findings suggested that the presence of cholesterol moieties could control AMB loading and release properties. Dendritic micelles inhibited AMB hemolysis and cytotoxicity in HEK 293 and RAW 264.7 cell lines while increasing antifungal activity against C. albicans biofilm formation. Furthermore, significantly lower levels of renal and liver toxicity biomarkers compared to Fungizone® ensured AMB-incorporated dendritic micelle biosafety, which was confirmed by histopathological evaluations. Overall, the Chol-HPG and HPG@Chol dendritic micelles may be a viable alternative to commercially available AMB formulations as well as an effective delivery system for other poorly soluble antifungal agents.
Collapse
Affiliation(s)
- Mahboobeh Jafari
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran
| | - Samira Sadat Abolmaali
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran
| | - Sedigheh Borandeh
- Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran
| | - Haniyeh Najafi
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran
| | - Zahra Zareshahrabadi
- Department of Parasitology & Mycology, School of Medicines, Shiraz University of Medical Sciences, Shiraz, PO Box 713484-5794, Iran
| | - Reza Heidari
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran
| | - Negar Azarpira
- Transplant Research Center, Shiraz University of Medical Sciences, Mohammad Rasoul-allah Research Tower, Shiraz, PO Box 7193711351, Iran
| | - Kamiar Zomorodian
- Department of Parasitology & Mycology, School of Medicines, Shiraz University of Medical Sciences, Shiraz, PO Box 713484-5794, Iran; Basic Sciences in Infectious Diseases Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, PO Box 713484-5794, Iran.
| | - Ali Mohammad Tamaddon
- Pharmaceutical Nanotechnology Department, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, PO Box 71345-1583, Iran.
| |
Collapse
|
4
|
Structure determination of hyperbranched polyester BOLTORN H40 by 1D- and 2D-NMR spectroscopy. Polym Bull (Berl) 2022. [DOI: 10.1007/s00289-022-04274-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
5
|
Fabrication of a magnetic nanocarrier for doxorubicin delivery based on hyperbranched polyglycerol and carboxymethyl cellulose: An investigation on the effect of borax cross-linker on pH-sensitivity. Int J Biol Macromol 2022; 203:80-92. [PMID: 35092736 DOI: 10.1016/j.ijbiomac.2022.01.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Revised: 01/20/2022] [Accepted: 01/24/2022] [Indexed: 11/22/2022]
Abstract
A new core-shell pH-responsive nanocarrier was prepared based on magnetic nanoparticle (MNP) core. Magnetic nanoparticles were first modified with hyperbranched polyglycerol as the first shell. Then the magnetic core was decorated with doxorubicin anticancer drug (DOX) and covered with PEGylated carboxymethylcellulose as the second shell. Borax was used to partially cross-link organic shells in order to evaluate drug loading content and pH-sensitivity. The structure of nanocarrier, organic shell loadings, magnetic responsibility, morphology, size, dispersibility, and drug loading content were investigated by IR, NMR, TG, VSM, XRD, DLS, HR-TEM and UV-Vis analyses. In vitro release investigations demonstrated that the use of borax as cross-linker between organic shells make the nanocarrier highly sensitive to pH so that more that 70% of DOX is released in acidic pH. A reverse pH-sensitivity was observed for the nanocarrier without borax cross-linker. The MTT assay determined that the nanocarrier exhibited excellent biocompatibility toward normal cells (HEK-293) and high toxicity against cancerous cells (HeLa). The nanocarrier also showed high hemocompatibility. Cellular uptake revealed high ability of nanocarrier toward HeLa cells comparable with free DOX. The results also suggested that low concentration of nanocarrier has a great potential for use as contrast agent in magnetic resonance imaging (MRI).
Collapse
|
6
|
Rancan F, Guo X, Rajes K, Sidiropoulou P, Zabihi F, Hoffmann L, Hadam S, Blume-Peytavi U, Rühl E, Haag R, Vogt A. Topical Delivery of Rapamycin by Means of Microenvironment-Sensitive Core-Multi-Shell Nanocarriers: Assessment of Anti-Inflammatory Activity in an ex vivo Skin/T Cell Co-Culture Model. Int J Nanomedicine 2021; 16:7137-7151. [PMID: 34712046 PMCID: PMC8548260 DOI: 10.2147/ijn.s330716] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 09/09/2021] [Indexed: 01/16/2023] Open
Abstract
Introduction Rapamycin (Rapa) is an immunosuppressive macrolide that inhibits the mechanistic target of rapamycin (mTOR) activity. Thanks to its anti-proliferative effects towards different cell types, including keratinocytes and T cells, Rapa shows promise in the treatment of skin diseases characterized by cell hyperproliferation. However, Rapa skin penetration is limited due to its lipophilic nature (log P = 4.3) and high molecular weight (MW = 914 g/mol). In previous studies, new microenvironment-sensitive core multishell (CMS) nanocarriers capable of sensing the redox state of inflamed skin were developed as more efficient and selective vehicles for macrolide delivery to inflamed skin. Methods In this study, we tested such redox-sensitive CMS nanocarriers using an inflammatory skin model based on human skin explants co-cultured with Jurkat T cells. Serine protease (SP) was applied on skin surface to induce skin barrier impairment and oxidative stress, whereas phytohaemagglutinin (PHA), IL-17A, and IL-22 were used to activate Jurkat cells. Activation markers, such as CD45 and CD69, phosphorylated ribosomal protein S6 (pRP-S6), and IL-2 release were monitored in activated T cells, whereas pro-inflammatory cytokines were measured in skin extracts and culture medium. Results We found that alteration of skin barrier proteins corneodesmosin (CDSN), occludin (Occl), and zonula occludens-1 (ZO-1) as well as oxidation-induced decrease of free thiol groups occurred upon SP-treatment. All Rapa formulations exerted inhibitory effects on T cells after penetration across ex vivo skin. No effects on skin inflammatory markers were detected. The superiority of the oxidative-sensitive CMS nanocarriers over the other formulations was observed with regard to drug delivery as well as downregulation of IL-2 release. Conclusion Overall, our results demonstrate that nanocarriers addressing features of diseased skin are promising approaches to improve the topical delivery of macrolide drugs.
Collapse
Affiliation(s)
- Fiorenza Rancan
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Xiao Guo
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Keerthana Rajes
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
| | - Polytimi Sidiropoulou
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Fatemeh Zabihi
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
| | - Luisa Hoffmann
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Sabrina Hadam
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Ulrike Blume-Peytavi
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Eckart Rühl
- Physical Chemistry, Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
| | - Rainer Haag
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
| | - Annika Vogt
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| |
Collapse
|
7
|
Rajes K, Walker KA, Hadam S, Zabihi F, Rancan F, Vogt A, Haag R. Redox-Responsive Nanocarrier for Controlled Release of Drugs in Inflammatory Skin Diseases. Pharmaceutics 2020; 13:pharmaceutics13010037. [PMID: 33383706 PMCID: PMC7823658 DOI: 10.3390/pharmaceutics13010037] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 12/18/2020] [Accepted: 12/23/2020] [Indexed: 12/18/2022] Open
Abstract
A synthetic route for redox-sensitive and non-sensitive core multi-shell (CMS) carriers with sizes below 20 nm and narrow molecular weight distributions was established. Cyclic voltammetric measurements were conducted characterizing the redox potentials of reduction-sensitive CMS while showcasing its reducibility through glutathione and tris(2-carboxyethyl)-phosphine as a proof of concept. Measurements of reduction-initiated release of the model dye Nile red by time-dependent fluorescence spectroscopy showed a pronounced release for the redox-sensitive CMS nanocarrier (up to 90% within 24 h) while the non-sensitive nanocarriers showed no release in PBS. Penetration experiments using ex vivo human skin showed that the redox-sensitive CMS nanocarrier could deliver higher percentages of the loaded macrocyclic dye meso-tetra (m-hydroxyphenyl) porphyrin (mTHPP) to the skin as compared to the non-sensitive CMS nanocarrier. Encapsulation experiments showed that these CMS nanocarriers can encapsulate dyes or drugs with different molecular weights and hydrophobicity. A drug content of 1 to 6 wt% was achieved for the anti-inflammatory drugs dexamethasone and rapamycin as well as fluorescent dyes such as Nile red and porphyrins. These results show that redox-initiated drug release is a promising strategy to improve the topical drug delivery of macrolide drugs.
Collapse
Affiliation(s)
- Keerthana Rajes
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany;
| | - Karolina A. Walker
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany;
- Correspondence: (K.A.W.); (R.H.); Tel.: +49-030-8385-2633 (R.H.)
| | - Sabrina Hadam
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (S.H.); (F.Z.); (F.R.); (A.V.)
| | - Fatemeh Zabihi
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (S.H.); (F.Z.); (F.R.); (A.V.)
| | - Fiorenza Rancan
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (S.H.); (F.Z.); (F.R.); (A.V.)
| | - Annika Vogt
- Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (S.H.); (F.Z.); (F.R.); (A.V.)
| | - Rainer Haag
- Institute of Chemistry and Biochemistry, Freie Universität Berlin, Takustr. 3, 14195 Berlin, Germany;
- Correspondence: (K.A.W.); (R.H.); Tel.: +49-030-8385-2633 (R.H.)
| |
Collapse
|
8
|
Pukale SS, Sharma S, Dalela M, Singh AK, Mohanty S, Mittal A, Chitkara D. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice. Acta Biomater 2020; 115:393-409. [PMID: 32846238 DOI: 10.1016/j.actbio.2020.08.020] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 08/02/2020] [Accepted: 08/18/2020] [Indexed: 12/17/2022]
Abstract
Lipid-polymer hybrid nanoparticles (LPNs) exhibit several advantages over polymeric and non-polymeric systems in terms of improved drug loading, controlled release, stability, and cellular uptake. Herein we report a scalable and stable monolithic lipid-polymer hybrid nanoparticles (LPNs) consisting of a combination of lipids (solid and liquid) and an amphiphilic copolymer, mPEG-PLA. Clobetasol propionate, a topical corticosteroid, was encapsulated in the hydrophobic core of these LPNs that showed spherical shaped particles with a z-average size of 94.8 nm (PDI = 0.213) and encapsulation efficiency of 84.3%. These clobetasol loaded LPNs (CP/LPNs) were formulated into a topical hydrogel using carbopol 974P. CP/LPNs gel showed a sustained in vitro clobetasol release for 7 days with no burst release and 6 month stability at 2-8°C and room temperature. Further, CP/LPNs showed an improved cellular uptake with significant growth inhibition of HaCaT cells. In ex vivo studies, these LPNs penetrated into the viable epidermis and dermis region of the psoriatic skin with undetectable quantities leaching to the reservoir. Further, the topical application of CP/LPNs gel on Swiss albino mice with psoriasis-like inflammation showed negligible leaching of clobetasol into the systemic circulation. Efficacy assessment showed significantly improved PASI score, reduced skin damage and proliferation after treatment with CP/LPNs gel as compared to marketed product (Clobetamos™). Collectively, the enhanced cellular uptake, high skin penetration with increased skin retention, and improved efficacy demonstrate the potential of these LPNs for future clinical application.
Collapse
|
9
|
Frombach J, Rancan F, Kübrich K, Schumacher F, Unbehauen M, Blume-Peytavi U, Haag R, Kleuser B, Sabat R, Wolk K, Vogt A. Serine Protease-Mediated Cutaneous Inflammation: Characterization of an Ex Vivo Skin Model for the Assessment of Dexamethasone-Loaded Core Multishell-Nanocarriers. Pharmaceutics 2020; 12:pharmaceutics12090862. [PMID: 32927792 PMCID: PMC7558872 DOI: 10.3390/pharmaceutics12090862] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Revised: 09/02/2020] [Accepted: 09/07/2020] [Indexed: 11/29/2022] Open
Abstract
Standard experimental set-ups for the assessment of skin penetration are typically performed on skin explants with an intact skin barrier or after a partial mechanical or chemical perturbation of the stratum corneum, but they do not take into account biochemical changes. Among the various pathological alterations in inflamed skin, aberrant serine protease (SP) activity directly affects the biochemical environment in the superficial compartments, which interact with topically applied formulations. It further impacts the skin barrier structure and is a key regulator of inflammatory mediators. Herein, we used short-term cultures of ex vivo human skin treated with trypsin and plasmin as inflammatory stimuli to assess the penetration and biological effects of the anti-inflammatory drug dexamethasone (DXM), encapsulated in core multishell-nanocarriers (CMS-NC), when compared to a standard cream formulation. Despite a high interindividual variability, the combined pretreatment of the skin resulted in an average 2.5-fold increase of the transepidermal water loss and swelling of the epidermis, as assessed by optical coherence tomography, as well as in a moderate increase of a broad spectrum of proinflammatory mediators of clinical relevance. The topical application of DXM-loaded CMS-NC or DXM standard cream revealed an increased penetration into SP-treated skin when compared to untreated control skin with an intact barrier. Both formulations, however, delivered sufficient amounts of DXM to effectively suppress the production of interleukin-6 (IL-6), interleukin-8 (IL-8) and Thymic Stromal Lymphopoietin (TSLP). In conclusion, we suggest that the herein presented ex vivo inflammatory skin model is functional and could improve the selection of promising drug delivery strategies for anti-inflammatory compounds at early stages of development.
Collapse
Affiliation(s)
- Janna Frombach
- Clinical Research Center for Hair and Skin Science, Department of Dermatology, Venereology and Allergy, Charité-Universitatsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (J.F.); (F.R.); (K.K.); (U.B.-P.)
| | - Fiorenza Rancan
- Clinical Research Center for Hair and Skin Science, Department of Dermatology, Venereology and Allergy, Charité-Universitatsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (J.F.); (F.R.); (K.K.); (U.B.-P.)
| | - Katharina Kübrich
- Clinical Research Center for Hair and Skin Science, Department of Dermatology, Venereology and Allergy, Charité-Universitatsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (J.F.); (F.R.); (K.K.); (U.B.-P.)
| | - Fabian Schumacher
- Institute of Nutritional Science, University of Potsdam, 14558 Nuthetal, Germany; (F.S.); (B.K.)
| | - Michael Unbehauen
- Organic Chemistry, Institute of Chemistry and Biochemistry, Freie Universitaet Berlin, 14195 Berlin, Germany; (M.U.); (R.H.)
| | - Ulrike Blume-Peytavi
- Clinical Research Center for Hair and Skin Science, Department of Dermatology, Venereology and Allergy, Charité-Universitatsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (J.F.); (F.R.); (K.K.); (U.B.-P.)
| | - Rainer Haag
- Organic Chemistry, Institute of Chemistry and Biochemistry, Freie Universitaet Berlin, 14195 Berlin, Germany; (M.U.); (R.H.)
| | - Burkhard Kleuser
- Institute of Nutritional Science, University of Potsdam, 14558 Nuthetal, Germany; (F.S.); (B.K.)
| | - Robert Sabat
- Psoriasis Research and Treatment Center, Department of Dermatology, Venerology and Allergy/Institute for Medical Immunology, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (R.S.); (K.W.)
| | - Kerstin Wolk
- Psoriasis Research and Treatment Center, Department of Dermatology, Venerology and Allergy/Institute for Medical Immunology, Charité-Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (R.S.); (K.W.)
| | - Annika Vogt
- Clinical Research Center for Hair and Skin Science, Department of Dermatology, Venereology and Allergy, Charité-Universitatsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany; (J.F.); (F.R.); (K.K.); (U.B.-P.)
- Correspondence:
| |
Collapse
|
10
|
Jafari M, Abolmaali SS, Najafi H, Tamaddon AM. Hyperbranched polyglycerol nanostructures for anti-biofouling, multifunctional drug delivery, bioimaging and theranostic applications. Int J Pharm 2020; 576:118959. [DOI: 10.1016/j.ijpharm.2019.118959] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2019] [Revised: 12/09/2019] [Accepted: 12/12/2019] [Indexed: 12/22/2022]
|
11
|
Zamboulis A, Nakiou EA, Christodoulou E, Bikiaris DN, Kontonasaki E, Liverani L, Boccaccini AR. Polyglycerol Hyperbranched Polyesters: Synthesis, Properties and Pharmaceutical and Biomedical Applications. Int J Mol Sci 2019; 20:E6210. [PMID: 31835372 PMCID: PMC6940955 DOI: 10.3390/ijms20246210] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2019] [Revised: 12/02/2019] [Accepted: 12/04/2019] [Indexed: 12/13/2022] Open
Abstract
In a century when environmental pollution is a major issue, polymers issued from bio-based monomers have gained important interest, as they are expected to be environment-friendly, and biocompatible, with non-toxic degradation products. In parallel, hyperbranched polymers have emerged as an easily accessible alternative to dendrimers with numerous potential applications. Glycerol (Gly) is a natural, low-cost, trifunctional monomer, with a production expected to grow significantly, and thus an excellent candidate for the synthesis of hyperbranched polyesters for pharmaceutical and biomedical applications. In the present article, we review the synthesis, properties, and applications of glycerol polyesters of aliphatic dicarboxylic acids (from succinic to sebacic acids) as well as the copolymers of glycerol or hyperbranched polyglycerol with poly(lactic acid) and poly(ε-caprolactone). Emphasis was given to summarize the synthetic procedures (monomer molar ratio, used catalysts, temperatures, etc.,) and their effect on the molecular weight, solubility, and thermal and mechanical properties of the prepared hyperbranched polymers. Their applications in pharmaceutical technology as drug carries and in biomedical applications focusing on regenerative medicine are highlighted.
Collapse
Affiliation(s)
- Alexandra Zamboulis
- Laboratory of Polymer Chemistry & Technology, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (A.Z.); (E.A.N.); (E.C.)
| | - Eirini A. Nakiou
- Laboratory of Polymer Chemistry & Technology, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (A.Z.); (E.A.N.); (E.C.)
| | - Evi Christodoulou
- Laboratory of Polymer Chemistry & Technology, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (A.Z.); (E.A.N.); (E.C.)
| | - Dimitrios N. Bikiaris
- Laboratory of Polymer Chemistry & Technology, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (A.Z.); (E.A.N.); (E.C.)
| | - Eleana Kontonasaki
- Department of Dentistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece;
| | - Liliana Liverani
- Institute of Biomaterials, Department of Material Science and Engineering, University of Erlangen-Nuremberg, Cauerstr. 6, 91058 Erlangen, Germany;
| | - Aldo R. Boccaccini
- Institute of Biomaterials, Department of Material Science and Engineering, University of Erlangen-Nuremberg, Cauerstr. 6, 91058 Erlangen, Germany;
| |
Collapse
|
12
|
Tailor‐Made Core‐Multishell Nanocarriers for the Delivery of Cationic Analgesics to Inflamed Tissue. ADVANCED THERAPEUTICS 2019. [DOI: 10.1002/adtp.201900007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
13
|
Gao L, Zabihi F, Ehrmann S, Hedtrich S, Haag R. Supramolecular nanogels fabricated via host-guest molecular recognition as penetration enhancer for dermal drug delivery. J Control Release 2019; 300:64-72. [PMID: 30797001 DOI: 10.1016/j.jconrel.2019.02.011] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2018] [Revised: 02/05/2019] [Accepted: 02/10/2019] [Indexed: 11/30/2022]
Abstract
Nanogels that are assembled by supramolecular interactions as compared to covalent crosslinked nanogels, exhibit new functionalities with potential for easy processability, recycling and self-healing due to the nature of dynamic and reversible non-covalent interactions. Here we design a supramolecular polymer nanogel that utilize host-guest interactions between the groups pillar [5] arene and alkyl chains on hyperbranched polyglycerol backbone as crosslinking agents for a new dermal drug delivery system. The anti-inflammatory drug Dexamethasone (Dexa) can be efficiently loaded into the nanogels and released from the assemblies. Besides, the supramolecular polymer nanogels exhibit better drug loading capacity and skin penetration enhancement than the individual host polymer and guest polymer. In vitro skin permeation studies show that supramolecular polymer nanogels can improve the Nile red penetration through the skin by up to 9 fold, compared to the individual polymers or a conventional cream formulation on a barrier deficient skin model.
Collapse
Affiliation(s)
- Lingyan Gao
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustrasse 3, 14195 Berlin, Germany
| | - Fatemeh Zabihi
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustrasse 3, 14195 Berlin, Germany; Institut für Pharmazie (Pharmakologie und Toxikologie), Freie Universität Berlin, 14195 Berlin, Germany
| | - Svenja Ehrmann
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustrasse 3, 14195 Berlin, Germany
| | - Sarah Hedtrich
- Institut für Pharmazie (Pharmakologie und Toxikologie), Freie Universität Berlin, 14195 Berlin, Germany; University of British Columbia, Faculty of Pharmaceutical Sciences, 2405 Wesbrook Mall, V6T1Z3 Vancouver, Canada
| | - Rainer Haag
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustrasse 3, 14195 Berlin, Germany.
| |
Collapse
|
14
|
Mishra DK, Shandilya R, Mishra PK. Lipid based nanocarriers: a translational perspective. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2018; 14:2023-2050. [PMID: 29944981 DOI: 10.1016/j.nano.2018.05.021] [Citation(s) in RCA: 115] [Impact Index Per Article: 19.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/01/2018] [Accepted: 05/28/2018] [Indexed: 12/11/2022]
|
15
|
Zabihi F, Graff P, Schumacher F, Kleuser B, Hedtrich S, Haag R. Synthesis of poly(lactide-co-glycerol) as a biodegradable and biocompatible polymer with high loading capacity for dermal drug delivery. NANOSCALE 2018; 10:16848-16856. [PMID: 30168550 DOI: 10.1039/c8nr05536j] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Due to the low cutaneous bioavailability of tacrolimus (TAC), penetration enhancers are used to improve its penetration into the skin. However, poor loading capacity, non-biodegradability, toxicity, and in some cases inefficient skin penetration are challenging issues that hamper their applications for the dermal TAC delivery. Here we present poly(lactide-co-glycerol) (PLG) as a water soluble, biodegradable, and biocompatible TAC-carrier with high loading capacity (14.5% w/w for TAC) and high drug delivery efficiencies into the skin. PLG was synthesized by cationic ring-opening copolymerization of a mixture of glycidol and lactide and showed 35 nm and 300 nm average sizes in aqueous solutions before and after loading of TAC, respectively. Delivery experiments on human skin, quantified by fluorescence microscopy and LC-MS/MS, showed a high ability for PLG to deposit Nile red and TAC into the stratum corneum and viable epidermis of skin in comparison with Protopic® (0.03% w/w, TAC ointment). The cutaneous distribution profile of delivered TAC proved that 80%, 16%, and 4% of the cutaneous drug level was deposited in the stratum corneum, viable epidermis, and upper dermis, respectively. TAC delivered by PLG was able to efficiently decrease the IL-2 and TSLP expressions in human skin models. Taking advantage of the excellent physicochemical and biological properties of PLG, it can be used for efficient dermal TAC delivery and potential treatment of inflammatory skin diseases.
Collapse
Affiliation(s)
- Fatemeh Zabihi
- Institut für Chemie und Biochemie, Freie Universität Berlin, Takustr. 3, 14195, Berlin, Germany.
| | | | | | | | | | | |
Collapse
|
16
|
Frombach J, Lohan SB, Lemm D, Gruner P, Hasler J, Ahlberg S, Blume-Peytavi U, Unbehauen M, Haag R, Meinke MC, Vogt A. Protease-mediated Inflammation: An In Vitro Human Keratinocyte-based Screening Tool for Anti-inflammatory Drug Nanocarrier Systems. ACTA ACUST UNITED AC 2018. [DOI: 10.1515/zpch-2017-1048] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Abstract
Background:
Refined encapsulation approaches in dermatotherapy gain increased interest. There is need of reproducible in vitro systems representing disease features to screen drug delivery systems for preclinical assessment. Inflammatory human skin diseases are commonly accompanied by abnormal epidermal differentiation and barrier impairment. Serine proteases (SPs) and their inhibitors play a critical role in such dysfunctional differentiation. SPs also initiate cellular pathways via activation of protease-activated receptors, which contribute to inflammation. Thus, function and activity of SPs should be considered for the design of new therapies of such disorders.
Objectives:
Herein, we established a novel simplified cell culture model, based on SP-mediated inflammation suitable to assess nanocarriers loaded with anti-inflammatory drugs.
Methods:
SP-mediated inflammation and the regulatory effect of free or encapsulated dexamethasone were determined by measuring interleukin-6 and interleukin-8 in culture medium of HaCaT (human adult low calcium temperature)-keratinocytes. Additionally, radical formation was analyzed by electron paramagnetic resonance spectroscopy. Cellular uptake of core-multishell nanocarriers was investigated by fluorescence microscopy. Cytotoxicity of all additives was determined by a viability assay.
Results:
SP-Stimulation of keratinocytes resulted in increased radical production and release of inflammatory cytokines without affecting cell viability. Induced inflammation was successfully downregulated by addition of free or encapsulated dexamethasone.
Conclusion:
SP-addition can be used as inflammatory stimulus in cell culture to mimic effects of aberrant enzymatic activities found in skin of atopic dermatitis patients. The set-up is appropriate as a preliminary test to examine the effectiveness of new molecules or delivery-systems to counteract serine protease-mediated inflammatory processes prior to skin studies.
Collapse
Affiliation(s)
- Janna Frombach
- Clinical Research Center for Hair and Skin Science , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Silke B. Lohan
- Center of Experimental and Applied Cutaneous Physiology , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Davina Lemm
- Clinical Research Center for Hair and Skin Science , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Paul Gruner
- Clinical Research Center for Hair and Skin Science , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Julia Hasler
- Center of Experimental and Applied Cutaneous Physiology , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Sebastian Ahlberg
- Center of Experimental and Applied Cutaneous Physiology , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Ulrike Blume-Peytavi
- Clinical Research Center for Hair and Skin Science , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Michael Unbehauen
- Freie Universität Berlin , Institut für Chemie und Biochemie , Berlin , Germany
| | - Rainer Haag
- Freie Universität Berlin , Institut für Chemie und Biochemie , Berlin , Germany
| | - Martina C. Meinke
- Center of Experimental and Applied Cutaneous Physiology , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin , Berlin , Germany
| | - Annika Vogt
- Clinical Research Center for Hair and Skin Science , Department of Dermatology, Venerology and Allergy , Charité – Universitätsmedizin Berlin, Charitéplatz 1 , Berlin , Germany , Phone: +4930450518207, 10117
| |
Collapse
|
17
|
Chen G, Wang Y, Xie R, Gong S. A review on core-shell structured unimolecular nanoparticles for biomedical applications. Adv Drug Deliv Rev 2018; 130:58-72. [PMID: 30009887 PMCID: PMC6149214 DOI: 10.1016/j.addr.2018.07.008] [Citation(s) in RCA: 48] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Revised: 06/23/2018] [Accepted: 07/09/2018] [Indexed: 12/12/2022]
Abstract
Polymeric unimolecular nanoparticles (NPs) exhibiting a core-shell structure and formed by a single multi-arm molecule containing only covalent bonds have attracted increasing attention for numerous biomedical applications. This unique single-molecular architecture provides the unimolecular NP with superior stability both in vitro and in vivo, a high drug loading capacity, as well as versatile surface chemistry, thereby making it a desirable nanoplatform for therapeutic and diagnostic applications. In this review, we surveyed the architecture of various types of polymeric unimolecular NPs, including water-dispersible unimolecular micelles and water-soluble unimolecular NPs used for the delivery of hydrophobic and hydrophilic agents, respectively, as well as their diverse biomedical applications. Future opportunities and challenges of unimolecular NPs were also briefly discussed.
Collapse
Affiliation(s)
- Guojun Chen
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institute for Discovery and Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA
| | - Yuyuan Wang
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institute for Discovery and Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA
| | - Ruosen Xie
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institute for Discovery and Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA
| | - Shaoqin Gong
- Department of Materials Science and Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; Wisconsin Institute for Discovery and Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53715, USA; Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53715, USA.
| |
Collapse
|
18
|
Döge N, Hadam S, Volz P, Wolf A, Schönborn KH, Blume-Peytavi U, Alexiev U, Vogt A. Identification of polystyrene nanoparticle penetration across intact skin barrier as rare event at sites of focal particle aggregations. JOURNAL OF BIOPHOTONICS 2018; 11:e201700169. [PMID: 29178669 DOI: 10.1002/jbio.201700169] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2017] [Accepted: 11/23/2017] [Indexed: 06/07/2023]
Abstract
The question whether nanoparticles can cross the skin barrier is highly debated. Even in intact skin rare events of deeper penetration have been reported, but technical limitations and possible artifacts require careful interpretation. In this study, horizontal scanning by 2-photon microscopy (2 PM) of full-thickness human skin samples placed in a lateral position yielded highly informative images for skin penetration studies of fluorescently tagged nanoparticles. Scanning of large fields of view allowed for detailed information on interfollicular and follicular penetration in tissue blocks without damaging the sample. Images in histomorphological correlation showed that 2P-excited fluorescence signals of fluorescently tagged 20 and 200 nm polystyrene nanoparticles preferentially accumulated in the stratum corneum (SC) and in the upper part of vellus hair follicles (HFs). Rare events of deeper penetration in the SC and in the infundibulum of vellus HFs were observed at sites of high focal particle aggregations. Wide-field 2 PM allows for imaging of nanoparticle penetration in large tissue blocks, whereas total internal reflection microscopy (TIRFM) enables selective detection of individual nanoparticles as well as clusters of nanoparticles in the SC and within the epidermal layer directly beneath the SC, thus confirming barrier crossing with high sensitivity.
Collapse
Affiliation(s)
- Nadine Döge
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Berlin, Germany
- Institute for Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, Berlin, Germany
| | - Sabrina Hadam
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Berlin, Germany
| | - Pierre Volz
- Department of Physics, Freie Universität Berlin, Berlin, Germany
| | - Alexander Wolf
- Department of Physics, Freie Universität Berlin, Berlin, Germany
| | | | - Ulrike Blume-Peytavi
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Berlin, Germany
| | - Ulrike Alexiev
- Department of Physics, Freie Universität Berlin, Berlin, Germany
| | - Annika Vogt
- Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Berlin, Germany
| |
Collapse
|
19
|
Jager J, Obst K, Lohan SB, Viktorov J, Staufenbiel S, Renz H, Unbehauen M, Haag R, Hedtrich S, Teutloff C, Meinke MC, Danker K, Dommisch H. Characterization of hyperbranched core-multishell nanocarriers as an innovative drug delivery system for the application at the oral mucosa. J Periodontal Res 2017; 53:57-65. [PMID: 28898420 DOI: 10.1111/jre.12487] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/01/2017] [Indexed: 12/25/2022]
Abstract
BACKGROUND AND OBJECTIVES In the oral cavity, the mucosal tissues may develop a number of different pathological conditions, such as inflammatory diseases (gingivitis, periodontitis) and autoimmune disorders (eg, oral lichen planus) that require therapy. The application of topical drugs is one common therapeutic approach. However, their efficacy is limited. Dilution effects due to saliva hinder the adherence and the penetration of drug formulations. Therefore, the bioavailability of oral topical drugs is insufficient, and patients may suffer from disease over years, if not life-long. MATERIAL AND METHODS In the present study, we characterized core-multishell (CMS) nanocarriers for their potential use as drug delivery systems at oral mucosal tissues. For this purpose, we prepared porcine masticatory as well as buccal mucosa and performed Franz cell diffusion experiments. Penetration of fluorescently labeled CMS nanocarriers into the mucosal tissue was analyzed using confocal laser scanning microscopy. Upon exposure to CMS nanocarriers, the metabolic and proliferative activity of gingival epithelial cells was determined by MTT and sulforhodamine B assays, respectively. RESULTS Here, we could show that the carriers penetrate into both mucosal tissues, while particles penetrate deeper into the masticatory mucosa. Electron paramagnetic resonance spectroscopy revealed that the 3-carboxy-2,2,5,5-tetramethyl-1-pyrrolidinyloxy-labeled glucocorticoid dexamethasone loaded on to the CMS nanocarriers was released from the carriers in both mucosal tissues but with a higher efficiency in the buccal mucosa. The release from the nanocarriers is in both cases superior compared to the release from a conventional cream, which is normally used for the treatment of inflammatory conditions in the oral cavity. The CMS nanocarriers exhibited neither cytotoxic nor proliferative effects in vitro. CONCLUSION These findings suggested that CMS nanocarriers might be an innovative approach for topical drug delivery in the treatment of oral inflammatory diseases.
Collapse
Affiliation(s)
- J Jager
- Institute for Biochemistry, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - K Obst
- Institute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, Berlin, Germany
| | - S B Lohan
- Department of Dermatology, Venerology and Allergology, Center of Experimental and Applied Cutaneous Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - J Viktorov
- Department of Periodontology and Synoptic Dentistry, Charité - Medical University Berlin, Berlin, Germany
| | - S Staufenbiel
- Institute of Pharmacy, Pharmaceutical Technology, Freie Universität Berlin, Berlin, Germany
| | - H Renz
- Department of Craniofacial Developmental Biology, Charité - Medical University Berlin, Berlin, Germany
| | - M Unbehauen
- Institute for Organic Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
| | - R Haag
- Institute for Organic Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany
| | - S Hedtrich
- Institute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, Berlin, Germany
| | - C Teutloff
- Department of Physics, Freie Universität Berlin, Berlin, Germany
| | - M C Meinke
- Department of Dermatology, Venerology and Allergology, Center of Experimental and Applied Cutaneous Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - K Danker
- Institute for Biochemistry, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - H Dommisch
- Department of Periodontology and Synoptic Dentistry, Charité - Medical University Berlin, Berlin, Germany.,Department of Oral Health Sciences, University of Washington, Seattle, WA, USA
| |
Collapse
|
20
|
|
21
|
Solubilization of phenols by multimolecular aggregates formed by low molecular weight hyperbranched polyglycidol. Colloids Surf A Physicochem Eng Asp 2017. [DOI: 10.1016/j.colsurfa.2017.02.032] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
22
|
Wong NKY, Shenoi RA, Abbina S, Chafeeva I, Kizhakkedathu JN, Khan MK. Nontransformed and Cancer Cells Can Utilize Different Endocytic Pathways To Internalize Dendritic Nanoparticle Variants: Implications on Nanocarrier Design. Biomacromolecules 2017; 18:2427-2438. [DOI: 10.1021/acs.biomac.7b00590] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Nelson K. Y. Wong
- Department
of Experimental Therapeutics, British Columbia Cancer Research Centre;
Radiation Oncology, British Columbia Cancer Agency − Vancouver Centre, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
| | - Rajesh A. Shenoi
- Centre
for Blood Research, Department of Pathology and Laboratory Medicine,
Department of Chemistry, University of British Columbia, Vancouver, Canada V6T 2B5
| | - Srinivas Abbina
- Centre
for Blood Research, Department of Pathology and Laboratory Medicine,
Department of Chemistry, University of British Columbia, Vancouver, Canada V6T 2B5
| | - Irina Chafeeva
- Centre
for Blood Research, Department of Pathology and Laboratory Medicine,
Department of Chemistry, University of British Columbia, Vancouver, Canada V6T 2B5
| | - Jayachandran N. Kizhakkedathu
- Centre
for Blood Research, Department of Pathology and Laboratory Medicine,
Department of Chemistry, University of British Columbia, Vancouver, Canada V6T 2B5
| | - Mohamed K. Khan
- Department
of Experimental Therapeutics, British Columbia Cancer Research Centre;
Radiation Oncology, British Columbia Cancer Agency − Vancouver Centre, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
- Radiation
Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ 85234, USA
| |
Collapse
|
23
|
Schwarzl R, Du F, Haag R, Netz RR. General method for the quantification of drug loading and release kinetics of nanocarriers. Eur J Pharm Biopharm 2017; 116:131-137. [DOI: 10.1016/j.ejpb.2016.12.015] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Revised: 10/20/2016] [Accepted: 12/20/2016] [Indexed: 10/20/2022]
|
24
|
Mohammadifar E, Zabihi F, Tu Z, Hedtrich S, Nemati Kharat A, Adeli M, Haag R. One-pot and gram-scale synthesis of biodegradable polyglycerols under ambient conditions: nanocarriers for intradermal drug delivery. Polym Chem 2017. [DOI: 10.1039/c7py01470h] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Biodegradable and biocompatible hyperbranched polymers are synthesized and their potential for dermal drug delivery is investigated.
Collapse
Affiliation(s)
- Ehsan Mohammadifar
- School of Chemistry
- University College of Science
- University of Tehran
- Tehran
- Iran
| | - Fatemeh Zabihi
- Institute of Chemistry and Biochemistry
- Freie Universität Berlin
- D-14195 Berlin
- Germany
- Institute of Pharmacy (Pharmacology and Toxicology)
| | - Zhaoxu Tu
- Institute of Chemistry and Biochemistry
- Freie Universität Berlin
- D-14195 Berlin
- Germany
| | - Sarah Hedtrich
- Institute of Pharmacy (Pharmacology and Toxicology)
- Freie Universität Berlin
- 14195 Berlin
- Germany
| | - Ali Nemati Kharat
- School of Chemistry
- University College of Science
- University of Tehran
- Tehran
- Iran
| | - Mohsen Adeli
- Institute of Chemistry and Biochemistry
- Freie Universität Berlin
- D-14195 Berlin
- Germany
- Department of Chemistry
| | - Rainer Haag
- Institute of Chemistry and Biochemistry
- Freie Universität Berlin
- D-14195 Berlin
- Germany
| |
Collapse
|
25
|
Sun Y, Du X, He J, Hu J, Zhang M, Ni P. Dual-responsive core-crosslinked polyphosphoester-based nanoparticles for pH/redox-triggered anticancer drug delivery. J Mater Chem B 2017; 5:3771-3782. [DOI: 10.1039/c7tb00440k] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
The paper focuses on the preparation of biodegradable pH/redox dual-responsive core-crosslinked nanoparticles loaded with dual anticancer drugs PTX and DOX via synergetic electrostatic as well as hydrophobic interactions and their further application in tumor chemotherapy.
Collapse
Affiliation(s)
- Yue Sun
- College of Chemistry
- Chemical Engineering and Materials Science
- State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials
- Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application
- Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis
| | - Xueqiong Du
- College of Chemistry
- Chemical Engineering and Materials Science
- State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials
- Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application
- Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis
| | - Jinlin He
- College of Chemistry
- Chemical Engineering and Materials Science
- State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials
- Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application
- Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis
| | - Jian Hu
- College of Chemistry
- Chemical Engineering and Materials Science
- State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials
- Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application
- Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis
| | - Mingzu Zhang
- College of Chemistry
- Chemical Engineering and Materials Science
- State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials
- Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application
- Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis
| | - Peihong Ni
- College of Chemistry
- Chemical Engineering and Materials Science
- State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials
- Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application
- Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis
| |
Collapse
|
26
|
Cheng DB, Yang PP, Cong Y, Liu FH, Qiao ZY, Wang H. One-pot synthesis of pH-responsive hyperbranched polymer–peptide conjugates with enhanced stability and loading efficiency for combined cancer therapy. Polym Chem 2017. [DOI: 10.1039/c7py00101k] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Nanoparticles as drug-delivery systems have received significant attention due to their merits such as prolonged circulation time and passive targeting of a tumor site.
Collapse
Affiliation(s)
- Dong-Bing Cheng
- CAS Center for Excellence in Nanoscience
- Laboratory for Biological Effects of Nanomaterials and Nanosafety
- National Center for Nanoscience and Technology (NCNST)
- Beijing
- China
| | - Pei-Pei Yang
- CAS Center for Excellence in Nanoscience
- Laboratory for Biological Effects of Nanomaterials and Nanosafety
- National Center for Nanoscience and Technology (NCNST)
- Beijing
- China
| | - Yong Cong
- CAS Center for Excellence in Nanoscience
- Laboratory for Biological Effects of Nanomaterials and Nanosafety
- National Center for Nanoscience and Technology (NCNST)
- Beijing
- China
| | - Fu-Hua Liu
- CAS Center for Excellence in Nanoscience
- Laboratory for Biological Effects of Nanomaterials and Nanosafety
- National Center for Nanoscience and Technology (NCNST)
- Beijing
- China
| | - Zeng-Ying Qiao
- CAS Center for Excellence in Nanoscience
- Laboratory for Biological Effects of Nanomaterials and Nanosafety
- National Center for Nanoscience and Technology (NCNST)
- Beijing
- China
| | - Hao Wang
- CAS Center for Excellence in Nanoscience
- Laboratory for Biological Effects of Nanomaterials and Nanosafety
- National Center for Nanoscience and Technology (NCNST)
- Beijing
- China
| |
Collapse
|
27
|
Omar H, Croissant JG, Alamoudi K, Alsaiari S, Alradwan I, Majrashi MA, Anjum DH, Martins P, Laamarti R, Eppinger J, Moosa B, Almalik A, Khashab NM. Biodegradable Magnetic Silica@Iron Oxide Nanovectors with Ultra-Large Mesopores for High Protein Loading, Magnetothermal Release, and Delivery. J Control Release 2016; 259:187-194. [PMID: 27913308 DOI: 10.1016/j.jconrel.2016.11.032] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Revised: 11/08/2016] [Accepted: 11/27/2016] [Indexed: 10/20/2022]
Abstract
The delivery of large cargos of diameter above 15nm for biomedical applications has proved challenging since it requires biocompatible, stably-loaded, and biodegradable nanomaterials. In this study, we describe the design of biodegradable silica-iron oxide hybrid nanovectors with large mesopores for large protein delivery in cancer cells. The mesopores of the nanomaterials spanned from 20 to 60nm in diameter and post-functionalization allowed the electrostatic immobilization of large proteins (e.g. mTFP-Ferritin, ~534kDa). Half of the content of the nanovectors was based with iron oxide nanophases which allowed the rapid biodegradation of the carrier in fetal bovine serum and a magnetic responsiveness. The nanovectors released large protein cargos in aqueous solution under acidic pH or magnetic stimuli. The delivery of large proteins was then autonomously achieved in cancer cells via the silica-iron oxide nanovectors, which is thus a promising for biomedical applications.
Collapse
Affiliation(s)
- Haneen Omar
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Jonas G Croissant
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Kholod Alamoudi
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Shahad Alsaiari
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Ibrahim Alradwan
- Life sciences and Environment Research Institute, Center of Excellence in Nanomedicine (CENM), King Abdulaziz City for Science and Technology (KACST), Riyadh 11461, Saudi Arabia
| | - Majed A Majrashi
- Life sciences and Environment Research Institute, Center of Excellence in Nanomedicine (CENM), King Abdulaziz City for Science and Technology (KACST), Riyadh 11461, Saudi Arabia
| | - Dalaver H Anjum
- Imaging and Characterization Laboratory, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Patricia Martins
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Ria Laamarti
- KAUST Catalysis Center (KCC), Physical Science and Engineering Division, King Abdullah University of Science and Technology (KAUST)
| | - Jorg Eppinger
- KAUST Catalysis Center (KCC), Physical Science and Engineering Division, King Abdullah University of Science and Technology (KAUST)
| | - Basem Moosa
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia
| | - Abdulaziz Almalik
- Life sciences and Environment Research Institute, Center of Excellence in Nanomedicine (CENM), King Abdulaziz City for Science and Technology (KACST), Riyadh 11461, Saudi Arabia.
| | - Niveen M Khashab
- Smart Hybrid Materials Laboratory, Advanced Membranes and Porous Materials Center, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia..
| |
Collapse
|